Melinta Therapeutics, Inc. (NASDAQ: MLNT) presented findings at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting highlighting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE